All news from Thoracic Medicine

Study Shows Frailty Linked To Poor Health In COPD

Patients with chronic obstructive pulmonary disease (COPD) who were classified as frail were more likely to have lower quality of life, increased rate and length of hospitalization, and a higher rate of mortality compared with non-frail patients, according to the results of a study published in the  Annals of the American Thoracic Society .

Thoracic Success in Malignant Pleural Effusion

Researchers from the University of Oxford in the United Kingdom found that a pleural adherence score derived from thoracic ultrasound (TUS) at 24 hours post-talc administration is predictive of long-term pleurodesis success in patients with symptomatic malignant pleural effusion (MPE). Findings were published in CHEST.

Resuscitative Aortic Occlusion: Effectiveness of Lower Profile Device

A new, lower profile device appears to be safe and effective for resuscitative endovascular balloon occlusion of the aorta (REBOA) in patients with blunt trauma, researchers report.

REBOA has been used for decades to control various types of hemorrhage below the diaphragm. The earliest experience with REBOA involved long platform guidewires and large introducer sheaths (12 Fr), but in 2015 a smaller profile device with a 7 Fr introducer sheath and no platform guidewire was approved. 

A Median 6.8 Years after Stage IV ALK+ Lung Cancer Diagnosis: Optimistic story

According to the National Cancer Institute, patients diagnosed with non-small cell lung cancer (NSCLC) between the years 1995 and 2001 had 15 percent chance of being alive 5 years later. For patients with stage IV disease, describing cancer that has spread to distant sites beyond the original tumor, that statistic drops to 2 percent. Now to University of Colorado Cancer Center study published in the  Journal of Thoracic Oncology tells a much more optimistic story.

OSA Patients: Slow-Release Morphine May Be Safe for Some

A 40-mg dose of slow-release morphine may be safe for non-severely obese patients with obstructive sleep apnea (OSA), researchers in Australia report.  "Slow-release morphine did not seem to be the OSA of the men in our study." For most of the men, there were no differences in breathing during sleep whether they received oral 40-mg slow-release morphine or placebo, "said Dr. David Wang.